{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:42:28Z","timestamp":1774536148182,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bone.2021.116000","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T05:45:56Z","timestamp":1620452756000},"page":"116000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Bone density and quality in patients treated with direct-acting oral anticoagulants versus warfarin"],"prefix":"10.1016","volume":"150","author":[{"given":"Jeferson Zanovelli","family":"Nalevaiko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falia Vieira Oberger","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus Felipe","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur William Passos","family":"Raetsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Lenci","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Rasmussen","family":"Petterle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina Aguiar","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vict\u00f3ria Zeghbi Cochenski","family":"Borba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bone.2021.116000_bb0005","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0034-1543999","article-title":"Oral anticoagulant drugs and the risk of osteoporosis: new anticoagulants better than old?","volume":"41","author":"Tufano","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.bone.2021.116000_bb0010","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1203\/01.PDR.0000155943.07244.04","article-title":"Reduced bone density in children on long-term warfarin","volume":"57","author":"Barnes","year":"2005","journal-title":"Pediatr. Res."},{"issue":"2","key":"10.1016\/j.bone.2021.116000_bb0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1756-185X.2009.01395.x","article-title":"Reduced bone density in patients on long-term warfarin","volume":"12","author":"Rezaieyazdi","year":"2009","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.bone.2021.116000_bb0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbacli.2015.08.002","article-title":"Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis","volume":"4","author":"Namba","year":"2015","journal-title":"BBA Clin."},{"issue":"12","key":"10.1016\/j.bone.2021.116000_bb0025","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1161\/01.STR.28.12.2390","article-title":"Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation","volume":"28","author":"Sato","year":"1997","journal-title":"Stroke."},{"issue":"1","key":"10.1016\/j.bone.2021.116000_bb0030","first-page":"133","article-title":"DOACs \u2013 advances and limitations in real world","volume":"17","author":"Lee","year":"2016","journal-title":"Thromb. J."},{"issue":"390","key":"10.1016\/j.bone.2021.116000_bb0035","first-page":"1211","volume":"2017","author":"GBD","year":"2016","journal-title":"Lancet."},{"issue":"11","key":"10.1016\/j.bone.2021.116000_bb0040","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis: a major contributor to global disease burden","volume":"34","author":"Raskob","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.bone.2021.116000_bb0045","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.bone.2021.116000_bb0050","article-title":"Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism","volume":"2014","author":"Middeldorp","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.bone.2021.116000_bb0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/jcm7020029","article-title":"A practical review of the emerging direct anticoagulants, laboratory monitoring, and reversal agents","volume":"7","author":"Joppa","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bone.2021.116000_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12891-015-0502-9","article-title":"Rivaroxaban does not impair fracture healing in a rat femur fracture model: an experimental study","volume":"16","author":"Kl\u00fcter","year":"2015","journal-title":"BMC Musculoskelet. Disord."},{"issue":"7","key":"10.1016\/j.bone.2021.116000_bb0065","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/jth.14467","article-title":"Evaluating utilization patterns of oral anticoagulants in routine care","volume":"17","author":"Gopalakrishnan","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.bone.2021.116000_bb0070","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1111\/bcp.13985","article-title":"A systematic review of patient-reported outcomes associated with the use of direct-acting oral anticoagulants","volume":"85","author":"Afzal","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.bone.2021.116000_bb0075","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3889\/oamjms.2019.289","article-title":"DOACs vs vitamin K antagonists: a comparison of phase III clinical trials and a prescriber support tool","volume":"7","author":"Pirlog","year":"2019","journal-title":"Open Access Maced J Med Sci."},{"issue":"3","key":"10.1016\/j.bone.2021.116000_bb0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.chest.2019.04.108","article-title":"Effectiveness and safety of four direct oral anticoagulants in Asian patients with nonvalvular atrial fibrillation","volume":"156","author":"Chan","year":"2019","journal-title":"Chest."},{"issue":"5","key":"10.1016\/j.bone.2021.116000_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026486","article-title":"Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin: a sequential cohort study","volume":"9","author":"Pratt","year":"2019","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.bone.2021.116000_bb0090","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/clc.23196","article-title":"Anticoagulation in chronic kidney disease: from guidelines to clinical practice","volume":"42","author":"Aursulesei","year":"2019","journal-title":"Clin. Cardiol."},{"issue":"3","key":"10.1016\/j.bone.2021.116000_bb0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11239-019-01878-x","article-title":"Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism","volume":"48","author":"Giustozzi","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"issue":"3","key":"10.1016\/j.bone.2021.116000_bb0100","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11239-019-01871-4","article-title":"Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer: a systematic review and meta-analysis","volume":"48","author":"Dong","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"issue":"21","key":"10.1016\/j.bone.2021.116000_bb0105","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.3390\/ijms20215275","article-title":"Anticoagulants and osteoporosis","volume":"20","author":"Signorelli","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bone.2021.116000_bb0110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1590\/S0482-50042009000200008","article-title":"C\u00e1lcio diet\u00e9tico \u2013 estrat\u00e9gias para otimizar o consumo","volume":"49","author":"Pereira","year":"2009","journal-title":"Rev. Bras. Reumatol."},{"key":"10.1016\/j.bone.2021.116000_bb0115","unstructured":"International Osteoporosis Foundation. Calcium content of common foods. Available from: https:\/\/www.iofbonehealth.org\/osteoporosis-musculoskeletal-disorders\/osteoporosis\/prevention\/calcium\/calcium-content-common-foods."},{"key":"10.1016\/j.bone.2021.116000_bb0120","unstructured":"International Osteoporosis Foundation. Calcium \u2013 recommended daily calcium intakes. Available from: https:\/\/www.iofbonehealth.org\/osteoporosis-musculoskeletal-disorders\/osteoporosis\/prevention\/calcium."},{"issue":"2","key":"10.1016\/j.bone.2021.116000_bb0125","first-page":"5","article-title":"Question\u00e1rio internacional de atividade f\u00edsica (IPAQ): estudo de validade e reprodutibilidade no Brasil","volume":"6","author":"Matsudo","year":"2012","journal-title":"Rev Bras Ativ F\u00eds Sa\u00fade."},{"key":"10.1016\/j.bone.2021.116000_bb0130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11657-015-0224-5","article-title":"Incidence of hip fracture in Brazil and the development of a FRAX model","volume":"10","author":"Zerbini","year":"2015","journal-title":"Arch. Osteoporos."},{"issue":"1","key":"10.1016\/j.bone.2021.116000_bb0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11657-020-00770-z","article-title":"Trabecular bone score (TBS) and bone mineral density in patients with long-term therapy with warfarin","volume":"15","author":"Marques","year":"2020","journal-title":"Arch. Osteoporos."},{"issue":"7","key":"10.1016\/j.bone.2021.116000_bb0140","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2021.116000_bb0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jocd.2013.08.004","article-title":"Executive summary of the 2013 international society for clinical densitometry position development conference on bone densitometry","volume":"16","author":"Schousboe","year":"2013","journal-title":"J. Clin. Densitom."},{"issue":"5","key":"10.1016\/j.bone.2021.116000_bb0150","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/jbmr.2734","article-title":"A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX","volume":"31","author":"McCloskey","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2021.116000_bb0155","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2017.1363","article-title":"Association between dabigatran vs warfarin and risk of osteoporotic fractures among patients with nonvalvular atrial fibrillation","volume":"317","author":"Lau","year":"2017","journal-title":"JAMA."},{"key":"10.1016\/j.bone.2021.116000_bb0160","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fphar.2018.00348","article-title":"Non-vitamin K antagonist oral anticoagulants vs. warfarin at risk of fractures: a systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Gu","year":"2018","journal-title":"Front Pharmacol."},{"issue":"2","key":"10.1016\/j.bone.2021.116000_bb0165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archinte.166.2.241","article-title":"Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of atrial fibrillation 2","volume":"166","author":"Gage","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"17","key":"10.1016\/j.bone.2021.116000_bb0170","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2019.08.1025","article-title":"Osteoporotic fractures in patients with atrial fibrillation treated with conventional versus direct anticoagulants","volume":"74","author":"Binding","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.bone.2021.116000_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M19-3671","article-title":"Association between treatment with apixaban, dabigatran, rivaroxaban, or warfarin and risk for osteoporotic fractures among patients with atrial fibrillation","volume":"173","author":"Lau","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.bone.2021.116000_bb0180","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/jamainternmed.2019.5679","article-title":"Association of anticoagulant therapy with risk of fracture among patients with atrial fibrillation","volume":"180","author":"Lutsey","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.bone.2021.116000_bb0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/europace\/euaa242","article-title":"Non-vitamin K oral anticoagulants and risk of fractures: a systematic review and meta-analysis","volume":"23","author":"Mongkhon","year":"2021","journal-title":"Europace."},{"issue":"12","key":"10.1016\/j.bone.2021.116000_bb0190","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.bone.2021.116000_bb0195","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bone.2021.116000_bb0200","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.bone.2021.116000_bb0205","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2021.116000_bb0210","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-8-6","article-title":"Nutrient intakes related to osteoporotic fractures in men and women--the Brazilian osteoporosis study (BRAZOS)","volume":"8","author":"Pinheiro","year":"2009","journal-title":"Nutr. J."},{"issue":"4","key":"10.1016\/j.bone.2021.116000_bb0215","first-page":"341","article-title":"Avalia\u00e7\u00e3o de vitamina D por esta\u00e7\u00e3o do ano em adultos de uma cidade do sul do Brasil","volume":"48","author":"Gobbi","year":"2016","journal-title":"RBAC."},{"issue":"1","key":"10.1016\/j.bone.2021.116000_bb0220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jcem-64-1-59","article-title":"Impaired carboxylation of osteocalcin in warfarin-treated patients","volume":"64","author":"Menon","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.116000_bb0225","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0083-6729(07)00016-7","article-title":"Vitamin K and bone health in adult humans","volume":"78","author":"B\u00fcgel","year":"2008","journal-title":"Vitam. Horm."},{"issue":"2","key":"10.1016\/j.bone.2021.116000_bb0230","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11606-018-4758-2","article-title":"A systematic review and meta-analysis of the association between vitamin K antagonist use and fracture","volume":"34","author":"Fiordellisi","year":"2019","journal-title":"J. Gen. Intern. Med."},{"issue":"3","key":"10.1016\/j.bone.2021.116000_bb0235","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1590\/S0034-89102010000300011","article-title":"Risk factors for osteoporotic fractures and low bone density in pre and postmenopausal women","volume":"44","author":"Pinheiro","year":"2010","journal-title":"Rev. Saude Publica"},{"issue":"5","key":"10.1016\/j.bone.2021.116000_bb0240","article-title":"Risk factors for osteoporosis: prevalence, change, and association with bone density","volume":"5","author":"Guthrie","year":"2000","journal-title":"Medscape Womens Health."},{"issue":"3","key":"10.1016\/j.bone.2021.116000_bb0245","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00774-009-0139-6","article-title":"Effects of different impact exercise modalities on bone mineral density in premenopausal women: a meta-analysis","volume":"28","author":"Martyn-St James","year":"2010","journal-title":"J. Bone Miner. Metab."},{"issue":"2","key":"10.1016\/j.bone.2021.116000_bb0250","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4103\/jfmpc.jfmpc_982_19","article-title":"Prevalence and risk factors for osteoporotic fracture among adults with comorbidities in Al-Ahsaa, Saudi Arabia","volume":"9","author":"Al Hamam","year":"2020","journal-title":"J Family Med Prim Care."},{"issue":"12","key":"10.1016\/j.bone.2021.116000_bb0255","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1007\/s00198-005-2003-4","article-title":"Bone health in urban midlife Malaysian women: risk factors and prevention","volume":"16","author":"Lim","year":"2005","journal-title":"Osteoporos. Int."},{"issue":"2","key":"10.1016\/j.bone.2021.116000_bb0260","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1359\/jbmr.061014","article-title":"Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the rancho Bernardo study","volume":"22","author":"Jassal","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2021.116000_bb0265","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00198-008-0608-0","article-title":"Renal function and rate of hip bone loss in older men: the osteoporotic fractures in men study","volume":"19","author":"Ishani","year":"2008","journal-title":"Osteoporos. Int."},{"issue":"9","key":"10.1016\/j.bone.2021.116000_bb0270","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00198-018-4592-8","article-title":"Association of renal function with bone mineral density and fracture risk in the longitudinal aging study Amsterdam","volume":"29","author":"Chen","year":"2018","journal-title":"Osteoporos. Int."},{"issue":"8","key":"10.1016\/j.bone.2021.116000_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133847","article-title":"Differential effects of dabigatran and warfarin on bone volume and structure in rats with normal renal function","volume":"10","author":"Fusaro","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bone.2021.116000_bb0280","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thromres.2012.08.304","article-title":"The effects of warfarin and edoxaban, an oral direct factor Xa inhibitor, on gammacarboxylated (Gla-osteocalcin) and undercarboxylated osteocalcin (uc-osteocalcin) in rats","volume":"131","author":"Morishima","year":"2013","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.bone.2021.116000_bb0285","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00380-017-0950-2","article-title":"Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation","volume":"32","author":"Namba","year":"2017","journal-title":"Heart Vessel."},{"issue":"2","key":"10.1016\/j.bone.2021.116000_bb0290","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013845","article-title":"Risk of osteoporosis in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants or warfarin","volume":"9","author":"Huang","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.bone.2021.116000_bb0295","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1590\/0004-2730000003456","article-title":"Trabecular bone score: perspectives of an imaging technology coming of age","volume":"58","author":"Silva","year":"2014","journal-title":"Arq Bras Endocrinol Metabol."},{"issue":"1","key":"10.1016\/j.bone.2021.116000_bb0300","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11657-019-0583-4","article-title":"Physical activity as measured by accelerometer in NHANES 2005-2006 is associated with better bone density and trabecular bone score in older adults","volume":"14","author":"Jain","year":"2019","journal-title":"Arch. Osteoporos."},{"issue":"2","key":"10.1016\/j.bone.2021.116000_bb0305","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/jc.2012-3118","article-title":"Manitoba bone density program. TBS (trabecular bone score) and diabetes-related fracture risk","volume":"98","author":"Leslie","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2021.116000_bb0310","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jocd.2016.04.001","article-title":"Trabecular Bone Score (TBS) and TBS-adjusted fracture risk assessment tool are potential supplementary tools for the discrimination of morphometric vertebral fractures in postmenopausal women with type 2 diabetes","volume":"19","author":"YJ","year":"2016","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bone.2021.116000_bb0315","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bone.2015.05.016","article-title":"Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice","volume":"78","author":"Harvey","year":"2015","journal-title":"Bone."},{"issue":"3","key":"10.1016\/j.bone.2021.116000_bb0320","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jocd.2015.06.008","article-title":"Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD official positions part 2: trabecular bone score","volume":"18","author":"Silva","year":"2015","journal-title":"J. Clin. Densitom."},{"issue":"1","key":"10.1016\/j.bone.2021.116000_bb0325","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11657-019-0602-5","article-title":"Associations between the lipid profile and the lumbar spine bone mineral density and trabecular bone score in elderly Iranian individuals participating in the Bushehr elderly health program: a population-based study","volume":"14","author":"Panahi","year":"2019","journal-title":"Arch. Osteoporos."},{"issue":"3","key":"10.1016\/j.bone.2021.116000_bb0330","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.tjog.2018.04.011","article-title":"A study of the value of trabecular bone score in fracture risk assessment of postmenopausal women","volume":"57","author":"Mirzaei","year":"2018","journal-title":"Taiwan J Obstet Gynecol."},{"key":"10.1016\/j.bone.2021.116000_bb0335","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1471-2474-12-247","article-title":"The effect of a new direct factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin","volume":"12","author":"Solayar","year":"2011","journal-title":"BMC Musculoskelet. Disord."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221001629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221001629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:55:25Z","timestamp":1757613325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221001629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":67,"alternative-id":["S8756328221001629"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116000","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone density and quality in patients treated with direct-acting oral anticoagulants versus warfarin","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116000"}}